We at MFOC are excited about what’s happening at Grail. These are the people doing the science part of our goal to develop a simple early detection test for cancer. They use ultra-deep sequencing to detect circulating tumor DNA. This has the potential to be the holy grail for early cancer detection in asymptomatic individuals.
Grail aims to enable the early detection of cancer in asymptomatic individuals through a blood screen – giving people the opportunity to fight cancer in the early stages and increase survival rates.
Please visit their website to learn more.